ONCY

#3899
Oncolytics Biotech, Inc. Common Shares
1.10 USD
+7.84%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.10
1.10
Intervallo Annuale
0.33
1.51
Variazione giornaliera
+7.84%
Variazione Mensile
+11.11%
Variazione di 6 mesi
-9.84%
Variazione Annuale
+89.66%
Chiusura Precedente
1.02
Apertura
1.10
Bid
Ask
Minimo
1.10
High
1.10
Volume
4
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 127.74 M
  • Employee 29
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DVS826
  • Industry Technology
Ricavi totali
Utile netto
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Notizie